John Woolford

John provides investor relations services to pharmaceutical and biotechnology companies with the goal of significantly impacting human health. Having worked as a microbiologist and transferred to the financial side of business, John has been able to use his unique perspective to assist many of our industry leading clients, including Jazz Pharmaceuticals, Array BioPharma, Incyte and West Pharmaceutical Services. He helped propel the investor and analyst communications of BioNTech while they developed their vaccine with Pfizer all through the COVID-19 pandemic. 

John helps our clients distill their incredibly scientific and detailed stories into an understandable narrative that is equally attractive to investors and analysts. 

In his free time, John enjoys heading to the Chesapeake Bay to go fishing or playing a few rounds of golf with friends.